发明名称 QUINAZOLINE DERIVATIVE HAVING TLR INHIBITORY ACTION
摘要 <P>PROBLEM TO BE SOLVED: To provide a novel compound which inhibits TLR 3, 7 and/or 9 and shows excellent effects of prevention and treatment of autoimmune diseases, inflammation, allergy and the like. <P>SOLUTION: There are provided a compound represented by general formula (1) [wherein R<SP POS="POST">1</SP>denotes a ring A or a ring A-B äthe ring A denotes a 5- to 7-membered saturated nitrogen-containing heterocyclic group or the like, and the ring B denotes a 6-10C aromatic ring group}; any one of R<SP POS="POST">2</SP>and R<SP POS="POST">4</SP>denotes a specific substituent containing the ring A or the ring B, or the like; the other of R<SP POS="POST">2</SP>and R<SP POS="POST">4</SP>denotes a hydrogen atom, hydroxyl, a halogen atom, a 1-10C alkyl group or a 1-10C alkyloxy group; and R<SP POS="POST">3</SP>, R<SP POS="POST">5</SP>and R<SP POS="POST">6</SP>may be the same or different and denote a hydrogen atom, hydroxyl, a halogen atom, a 1-10C alkyl group or a 1-10C alkyloxy group], or a salt thereof, or a solvate of them. <P>COPYRIGHT: (C)2013,JPO&INPIT
申请公布号 JP2013091624(A) 申请公布日期 2013.05.16
申请号 JP20110235425 申请日期 2011.10.26
申请人 KOWA CO 发明人 TAKEMURA SHUNJI;NISHIYAMA TATSUAKI;KOKETSU AKIYASU;AIDA TORU
分类号 C07D401/14;A61K31/517;A61P1/04;A61P9/00;A61P9/14;A61P11/06;A61P17/06;A61P19/02;A61P25/00;A61P29/00;A61P31/04;A61P37/00;A61P37/06;A61P37/08;A61P43/00 主分类号 C07D401/14
代理机构 代理人
主权项
地址